Gilead: Bad Apple in the Biotech Bunch?
Gilead Sciences is getting killed, but the biotechnology sector seems to be doing just fine. Gilead (GILD) dropped 10% today after it offered up a less rosy outlook than analysts expected. While the biotech juggernaut reported a profit and beat ...
Biotech giant Gilead is slipping after revealing its 2017 guidanceBusiness Insider
Don't Panic: Gilead Sciences Really Isn't a Value TrapMotley Fool
Biotech Stocks Worth a Closer Look: Gilead Sciences Inc. (NASDAQ:GILD), Ocera Therapeutics, Inc. (NASDAQ:OCRX)The Voice Registrar
all 293 news articles »
Stock Market Daily
Trinity Biotech’s (TRIB) CEO Ronan O’Caoimh on Q4 2016 Results – Earnings Call Transcript
Good day and welcome to the Trinity Biotech Fourth Quarter and Fiscal Year 2016 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask …
Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial ResultsP&T Community
Stock Returns: Surmodics Inc (NASDAQ:SRDX) is Beating Trinity Biotech plc (NASDAQ:TRIB)CML News
Trinity Biotech (NASDAQ:TRIB) reports 4Q16 Profit Down 60%Stock Market Daily
all 15 news articles »